Impaired insulin signaling and mechanisms of memory loss

Progress in Molecular Biology and Translational Science

Volumn 121, Issue , 2014, Pages 413-449

  Bloemer, Jenna ^a   Bhattacharya, Subhrajit ^a   Amin, Rajesh ^a   Suppiramaniam, Vishnu ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; central insulin resistance; cognitive impairment; diabetes; IGF 1; neurodegeneration

Indexed keywords

GLUCOSE; INSULIN;

AMNESIA; ARTICLE; CELL SURVIVAL; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; LEARNING; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ALZHEIMER'S DISEASE; CENTRAL INSULIN RESISTANCE; COGNITIVE IMPAIRMENT; DIABETES; IGF-1; NEURODEGENERATION;

ANIMALS; COGNITION; DIABETES MELLITUS; HUMANS; INSULIN; INSULIN RESISTANCE; MEMORY DISORDERS; SIGNAL TRANSDUCTION;

EID: 84896731087     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800101-1.00013-2     Document Type: Chapter

References (284)

1. C.J. Goodner, and M.A. Berrie The failure of rat hypothalamic tissues to take up labeled insulin in vivo or to respond to insulin in vitro Endocrinology 101 1977 605 612
2. J. Tang, Y. Pei, and G. Zhou When aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapy Exp Gerontol 48 2013 744 750
3. L. Li, and C. Holscher Common pathological processes in Alzheimer disease and type 2 diabetes: a review Brain Res Rev 56 2007 384 402
4. C.T. Kodl, and E.R. Seaquist Cognitive dysfunction and diabetes mellitus Endocr Rev 29 2008 494 511
5. S.M. de la Monte, and J.R. Wands Alzheimer's disease is type 3 diabetes-evidence reviewed J Diabetes Sci Technol 2 2008 1101 1113
6. T. Ohara, Y. Doi, and T. Ninomiya et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study Neurology 77 2011 1126 1134
7. H.H. Feldman, and C. Jacova Mild cognitive impairment Am J Geriatr Psychiatry 13 2005 645 655
8. S. Gandy The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease J Clin Invest 115 2005 1121 1129
9. C.C. Cowie, K.F. Rust, and E.S. Ford et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006 Diabetes Care 32 2009 287 294
10. D.E. Barnes, and K. Yaffe The projected effect of risk factor reduction on Alzheimer's disease prevalence Lancet Neurol 10 2011 819 828
11. W.R. Miles, and H.F. Root Psychologic tests applied to diabetic patients Arch Intern Med 30 1922 767 777
12. A.M. Brands, G.J. Biessels, E.H. de Haan, L.J. Kappelle, and R.P. Kessels The effects of type 1 diabetes on cognitive performance: a meta-analysis Diabetes Care 28 2005 726 735
13. C.M. Ryan Memory and metabolic control in children Diabetes Care 22 1999 1239 1241
14. E.J. Schoenle, D. Schoenle, L. Molinari, and R.H. Largo Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex Diabetologia 45 2002 108 114
15. A.M. Jacobson, G. Musen, and C.M. Ryan et al. Long-term effect of diabetes and its treatment on cognitive function N Engl J Med 356 2007 1842 1852
16. K. Yaffe, A. Kanaya, and K. Lindquist et al. The metabolic syndrome, inflammation, and risk of cognitive decline JAMA 292 2004 2237 2242
17. J.A. Luchsinger, M.X. Tang, Y. Stern, S. Shea, and R. Mayeux Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 2001 635 641
18. C. MacKnight, K. Rockwood, E. Awalt, and I. McDowell Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging Dement Geriatr Cogn Disord 14 2002 77 83
19. J.A. Luchsinger, C. Reitz, B. Patel, M.X. Tang, J.J. Manly, and R. Mayeux Relation of diabetes to mild cognitive impairment Arch Neurol 64 2007 570 575
20. E.M. Schrijvers, J.C. Witteman, E.J. Sijbrands, A. Hofman, P.J. Koudstaal, and M.M. Breteler Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study Neurology 75 2010 1982 1987
21. T. Cukierman, H.C. Gerstein, and J.D. Williamson Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies Diabetologia 48 2005 2460 2469
22. J.D. Curb, B.L. Rodriguez, and R.D. Abbott et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance Neurology 52 1999 971 975
23. D.G. Bruce, G.P. Casey, and V. Grange et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study Diabetes Res Clin Pract 61 2003 59 67
24. E.J. Austin, and I.J. Deary Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data Diabetes Care 22 1999 1273 1277
25. A.J. Sommerfield, I.J. Deary, V. McAulay, and B.M. Frier Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes Diabetes Care 26 2003 390 396
26. R. Stewart, and D. Liolitsa Type 2 diabetes mellitus, cognitive impairment and dementia Diabet Med 16 1999 93 112
27. M.W. Strachan, I.J. Deary, F.M. Ewing, and B.M. Frier Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies Diabetes Care 20 1997 438 445
28. A.M. Abbatecola, F. Lattanzio, and L. Spazzafumo et al. Adiposity predicts cognitive decline in older persons with diabetes: a 2-year follow-up PLoS One 5 2010 e10333
29. S. Craft, and G.S. Watson Insulin and neurodegenerative disease: shared and specific mechanisms Lancet Neurol 3 2004 169 178
30. B. Boden-Albala, S. Cammack, and J. Chong et al. Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS) Diabetes Care 31 2008 1132 1137
31. D.J. Cox, B.P. Kovatchev, and L.A. Gonder-Frederick et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes Diabetes Care 28 2005 71 77
32. S. Freude, L. Plum, and J. Schnitker et al. Peripheral hyperinsulinemia promotes tau phosphorylation in vivo Diabetes 54 2005 3343 3348
33. R.J. Anderson, K.E. Freedland, R.E. Clouse, and P.J. Lustman The prevalence of comorbid depression in adults with diabetes: a meta-analysis Diabetes Care 24 2001 1069 1078
34. L.D. Baker, D.J. Cross, S. Minoshima, D. Belongia, G.S. Watson, and S. Craft Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes Arch Neurol 68 2011 51 57
35. S. Craft Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation Neurobiol Aging 26 suppl 1 2005 65 69
36. K.F. Neumann, L. Rojo, L.P. Navarrete, G. Farias, P. Reyes, and R.B. Maccioni Insulin resistance and Alzheimer's disease: molecular links & clinical implications Curr Alzheimer Res 5 2008 438 447
37. K. Talbot, H.Y. Wang, and H. Kazi et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J Clin Invest 122 2012 1316 1338
38. J. Havrankova, J. Roth, and M. Brownstein Insulin receptors are widely distributed in the central nervous system of the rat Nature 272 1978 827 829
39. E.J. Rivera, A. Goldin, N. Fulmer, R. Tavares, J.R. Wands, and S.M. de la Monte Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine J Alzheimers Dis 8 2005 247 268
40. J.L. Marks, J. Maddison, and C.J. Eastman Subcellular localization of rat brain insulin binding sites J Neurochem 50 1988 774 781
41. C.R. Kahn, and M.F. White The insulin receptor and the molecular mechanism of insulin action J Clin Invest 82 1988 1151 1156
42. S. Jacobs, and P. Cuatrecasas Insulin receptor: structure and function Endocr Rev 2 1981 251 263
43. J. Lee, and P.F. Pilch The insulin receptor: structure, function, and signaling Am J Physiol 266 1994 C319 C334
44. A. Ullrich, J.R. Bell, and E.Y. Chen et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes Nature 313 1985 756 761
45. X.J. Sun, P. Rothenberg, and C.R. Kahn et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein Nature 352 1991 73 77
46. H.J. Goren, M.F. White, and C.R. Kahn Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity Biochemistry 26 1987 2374 2382
47. M.G. Myers Jr., X.J. Sun, and M.F. White The IRS-1 signaling system Trends Biochem Sci 19 1994 289 293
48. T. O'Hare, and P.F. Pilch Intrinsic kinase activity of the insulin receptor Int J Biochem 22 1990 315 324
49. M. Okamoto, T. Hayashi, and S. Kono et al. Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation Biochem J 290 Pt 2 1993 327 333
50. D.P. Brazil, and B.A. Hemmings Ten years of protein kinase B signalling: a hard Akt to follow Trends Biochem Sci 26 2001 657 664
51. L.L. Pearson, B.E. Castle, and M.R. Kehry CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways Int Immunol 13 2001 273 283
52. C. Sutherland, I.A. Leighton, and P. Cohen Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling Biochem J 296 Pt 1 1993 15 19
53. K. Siddle Signalling by insulin and IGF receptors: supporting acts and new players J Mol Endocrinol 47 2011 R1 R10
54. Y. Balaraman, A.R. Limaye, A.I. Levey, and S. Srinivasan Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance Cell Mol Life Sci 63 2006 1226 1235
55. J. Lee, and M.S. Kim The role of GSK3 in glucose homeostasis and the development of insulin resistance Diabetes Res Clin Pract 77 suppl 1 2007 S49 S57
56. B. Clodfelder-Miller, P. De Sarno, A.A. Zmijewska, L. Song, and R.S. Jope Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3 J Biol Chem 280 2005 39723 39731
57. J.M. Backer, M.G. Myers Jr., and X.J. Sun et al. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells J Biol Chem 268 1993 8204 8212
58. Z. Zhuang, X. Zhao, and Y. Wu et al. The anti-apoptotic effect of PI3K-Akt signaling pathway after subarachnoid hemorrhage in rats Ann Clin Lab Sci 41 2011 364 372
59. X.F. Zhang, J. Settleman, and J.M. Kyriakis et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 Nature 364 1993 308 313
60. C.A. Lange-Carter, C.M. Pleiman, A.M. Gardner, K.J. Blumer, and G.L. Johnson A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf Science 260 1993 315 319
61. R. Ghasemi, A. Haeri, L. Dargahi, Z. Mohamed, and A. Ahmadiani Insulin in the brain: sources, localization and functions Mol Neurobiol 47 2013 145 171
62. W.A. Banks The source of cerebral insulin Eur J Pharmacol 490 2004 5 12
63. S.C. Woods, R.J. Seeley, D.G. Baskin, and M.W. Schwartz Insulin and the blood-brain barrier Curr Pharm Des 9 2003 795 800
64. W.M. Pardridge, J. Eisenberg, and J. Yang Human blood-brain barrier insulin receptor J Neurochem 44 1985 1771 1778
65. A. Dorn, H.G. Bernstein, A. Rinne, M. Ziegler, H.J. Hahn, and S. Ansorge Insulin- and glucagonlike peptides in the brain Anat Rec 207 1983 69 77
66. A. Dorn, A. Rinne, H.G. Bernstein, H.J. Hahn, and M. Ziegler Insulin and C-peptide in human brain neurons (insulin/C-peptide/brain peptides/ immunohistochemistry/radioimmunoassay) J Hirnforsch 24 1983 495 499
67. L. Frolich, D. Blum-Degen, and H.G. Bernstein et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease J Neural Transm 105 1998 423 438
68. N.P. Birch, D.L. Christie, and A.G. Renwick Proinsulin-like material in mouse foetal brain cell cultures FEBS Lett 168 1984 299 302
69. R. Schechter, J. Whitmire, and G.S. Wheet et al. Immunohistochemical and in situ hybridization study of an insulin-like substance in fetal neuron cell cultures Brain Res 636 1994 9 27
70. S.U. Devaskar, S.J. Giddings, P.A. Rajakumar, L.R. Carnaghi, R.K. Menon, and D.S. Zahm Insulin gene expression and insulin synthesis in mammalian neuronal cells J Biol Chem 269 1994 8445 8454
71. W.S. Young 3rd. Periventricular hypothalamic cells in the rat brain contain insulin mRNA Neuropeptides 8 1986 93 97
72. R. Schechter, D. Beju, T. Gaffney, F. Schaefer, and L. Whetsell Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system Brain Res 736 1996 16 27
73. B.S. Singh, P.A. Rajakumar, E.M. Eves, M.R. Rosner, B.H. Wainer, and S.U. Devaskar Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines Regul Pept 69 1997 7 14
74. A. Dorn, A. Rinne, H.J. Hahn, H.G. Bernstein, and M. Ziegler C-peptide immunoreactive neurons in human brain Acta Histochem 70 1982 326 330
75. J. Wahren, K. Ekberg, and J. Johansson et al. Role of C-peptide in human physiology Am J Physiol Endocrinol Metab 278 2000 E759 E768
76. A.I. Duarte, P.I. Moreira, and C.R. Oliveira Insulin in central nervous system: more than just a peripheral hormone J Aging Res 2012 2012 384017
77. S. Hoyer Memory function and brain glucose metabolism Pharmacopsychiatry 36 suppl 1 2003 S62 S67
78. D.F. Hopkins, and G. Williams Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity Diabet Med 14 1997 1044 1050
79. L.P. van der Heide, G.M. Ramakers, and M.P. Smidt Insulin signaling in the central nervous system: learning to survive Prog Neurobiol 79 2006 205 221
80. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat Rev Mol Cell Biol 7 2006 85 96
81. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M.F. White The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J Biol Chem 275 2000 9047 9054
82. S. Frojdo, H. Vidal, and L. Pirola Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans Biochim Biophys Acta 1792 2009 83 92
83. X.J. Sun, and F. Liu Phosphorylation of IRS proteins Yin-Yang regulation of insulin signaling Vitam Horm 80 2009 351 387
84. S. Boura-Halfon, and Y. Zick Phosphorylation of IRS proteins, insulin action, and insulin resistance Am J Physiol Endocrinol Metab 296 2009 E581 E591
85. P. Gual, Y. Le Marchand-Brustel, and J.F. Tanti Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 87 2005 99 109
86. S. Boura-Halfon, and Y. Zick Serine kinases of insulin receptor substrate proteins Vitam Horm 80 2009 313 349
87. W.H. Stoothoff, and G.V. Johnson Tau phosphorylation: physiological and pathological consequences Biochim Biophys Acta 1739 2005 280 297
88. W. Noble, D.P. Hanger, C.C. Miller, and S. Lovestone The importance of tau phosphorylation for neurodegenerative diseases Front Neurol 4 2013 83
89. K. Mi, and G.V. Johnson The role of tau phosphorylation in the pathogenesis of Alzheimer's disease Curr Alzheimer Res 3 2006 449 463
90. L. Buee, T. Bussiere, V. Buee-Scherrer, A. Delacourte, and P.R. Hof Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res Brain Res Rev 33 2000 95 130
91. Y. Deng, B. Li, Y. Liu, K. Iqbal, I. Grundke-Iqbal, and C.X. Gong Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer's disease Am J Pathol 175 2009 2089 2098
92. C.G. Jolivalt, C.A. Lee, and K.K. Beiswenger et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin J Neurosci Res 86 2008 3265 3274
93. R. Bhat, Y. Xue, and S. Berg et al. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 J Biol Chem 278 2003 45937 45945
94. M. Schubert, D.P. Brazil, and D.J. Burks et al. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation J Neurosci 23 2003 7084 7092
95. P.I. Moreira, A.I. Duarte, M.S. Santos, A.C. Rego, and C.R. Oliveira An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease J Alzheimers Dis 16 2009 741 761
96. G. Drewes MARKing tau for tangles and toxicity Trends Biochem Sci 29 2004 548 555
97. L.Q. Zhu, S.H. Wang, and D. Liu et al. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments J Neurosci 27 2007 12211 12220
98. B. DaRocha-Souto, M. Coma, and B.G. Perez-Nievas et al. Activation of glycogen synthase kinase-3 beta mediates beta-amyloid induced neuritic damage in Alzheimer's disease Neurobiol Dis 45 2012 425 437
99. L. Xie, E. Helmerhorst, K. Taddei, B. Plewright, W. Van Bronswijk, and R. Martins Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor J Neurosci 22 2002 RC221
100. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end-products: a review Diabetologia 44 2001 129 146
101. G.M. Cole, and S.A. Frautschy The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease Exp Gerontol 42 2007 10 21
102. W.B. Stine Jr., K.N. Dahlgren, G.A. Krafft, and M.J. LaDu In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis J Biol Chem 278 2003 11612 11622
103. W.Q. Qiu, and M.F. Folstein Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis Neurobiol Aging 27 2006 190 198
104. V. Chesneau, R.K. Perlman, W. Li, G.A. Keller, and M.R. Rosner Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation Endocrinology 138 1997 3444 3451
105. H.G. Bernstein, S. Ansorge, P. Riederer, M. Reiser, L. Frolich, and B. Bogerts Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques Neurosci Lett 263 1999 161 164
106. W. Farris, S. Mansourian, and Y. Chang et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 2003 4162 4167
107. L. Gasparini, G.K. Gouras, and R. Wang et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling J Neurosci 21 2001 2561 2570
108. W.Q. Zhao, F.G. De Felice, and S. Fernandez et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors FASEB J 22 2008 246 260
109. X. Han, Y. Ma, and X. Liu et al. Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer's disease rat model J Neural Transm 119 2012 1407 1416
110. W.H. Zheng, S. Kar, S. Dore, and R. Quirion Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway J Neural Transm Suppl 2000 261 272
111. S. Dore, S. Bastianetto, S. Kar, and R. Quirion Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons Ann NY Acad Sci 890 1999 356 364
112. S. Dore, S. Kar, and R. Quirion Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity Proc Natl Acad Sci USA 94 1997 4772 4777
113. G.E. Garrido, S.S. Furuie, and C.A. Buchpiguel et al. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study J Neurol Neurosurg Psychiatry 73 2002 508 516
114. G.W. Small, L.M. Ercoli, and D.H. Silverman et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Proc Natl Acad Sci USA 97 2000 6037 6042
115. C. Sims-Robinson, B. Kim, A. Rosko, and E.L. Feldman How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 6 2010 551 559
116. J.V. Hunt, and S.P. Wolff Oxidative glycation and free radical production: a causal mechanism of diabetic complications Free Radic Res Commun 12-13 Pt 1 1991 115 123
117. M. Brownlee Advanced protein glycosylation in diabetes and aging Annu Rev Med 46 1995 223 234
118. G.J. Biessels, L.P. van der Heide, A. Kamal, R.L. Bleys, and W.H. Gispen Ageing and diabetes: implications for brain function Eur J Pharmacol 441 2002 1 14
119. D.K. Singh, P. Winocour, and K. Farrington Oxidative stress in early diabetic nephropathy: fueling the fire Nat Rev Endocrinol 7 2011 176 184
120. A.M. Vincent, J.W. Russell, P. Low, and E.L. Feldman Oxidative stress in the pathogenesis of diabetic neuropathy Endocr Rev 25 2004 612 628
121. J.W. Russell, A. Berent-Spillson, A.M. Vincent, C.L. Freimann, K.A. Sullivan, and E.L. Feldman Oxidative injury and neuropathy in diabetes and impaired glucose tolerance Neurobiol Dis 30 2008 420 429
122. P.I. Moreira, M.S. Santos, R. Seica, and C.R. Oliveira Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes J Neurol Sci 257 2007 206 214
123. S.M. de la Monte Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Curr Alzheimer Res 9 2012 35 66
124. W.D. Dietrich, O. Alonso, and R. Busto Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats Stroke 24 1993 111 116
125. J.M. Starr, J. Wardlaw, K. Ferguson, A. MacLullich, I.J. Deary, and I. Marshall Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging J Neurol Neurosurg Psychiatry 74 2003 70 76
126. H. Kamada, F. Yu, C. Nito, and P.H. Chan Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction Stroke 38 2007 1044 1049
127. Y. Serlin, J. Levy, and H. Shalev Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus Cardiovasc Psychiatry Neurol 2011 2011 609202
128. M.M. Anderson, J.R. Requena, J.R. Crowley, S.R. Thorpe, and J.W. Heinecke The myeloperoxidase system of human phagocytes generates Nepsilon- (carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation J Clin Invest 104 1999 103 113
129. S. Civelek, R. Gelisgen, and G. Andican et al. Advanced glycation end products and antioxidant status in nondiabetic and streptozotocin induced diabetic rats: effects of copper treatment Biometals 23 2010 43 49
130. V. Scivittaro, M.B. Ganz, and M.F. Weiss AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells Am J Physiol Renal Physiol 278 2000 F676 F683
131. A. Ceriello Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications Diabetes Nutr Metab 12 1999 42 46
132. J.W. Lustbader, M. Cirilli, and C. Lin et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
133. T. Nishikawa, D. Edelstein, and X.L. Du et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
134. G. Lenaz Role of mitochondria in oxidative stress and ageing Biochim Biophys Acta 1366 1998 53 67
135. P.I. Moreira, M.S. Santos, A.M. Moreno, R. Seica, and C.R. Oliveira Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure Diabetes 52 2003 1449 1456
136. R. Rizzuto, P. Bernardi, and T. Pozzan Mitochondria as all-round players of the calcium game J Physiol 529 Pt 1 2000 37 47
137. 2 + disregulation in diabetes mellitus Eur J Pharmacol 447 2002 201 209
138. E. Kostyuk, N. Voitenko, and I. Kruglikov et al. Diabetes-induced changes in calcium homeostasis and the effects of calcium channel blockers in rat and mice nociceptive neurons Diabetologia 44 2001 1302 1309
139. Z.S. Khachaturian Calcium hypothesis of Alzheimer's disease and brain aging Ann NY Acad Sci 747 1994 1 11
140. G. Biessels, and W.H. Gispen The calcium hypothesis of brain aging and neurodegenerative disorders: significance in diabetic neuropathy Life Sci 59 1996 379 387
141. M.J. Berridge Calcium hypothesis of Alzheimer's disease Pflugers Arch 459 2010 441 449
142. O. Thibault, J.C. Gant, and P.W. Landfield Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store Aging Cell 6 2007 307 317
143. M.R. Hovsepyan, M.J. Haas, and A.S. Boyajyan et al. Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus Neurosci Lett 369 2004 224 227
144. G.S. Hotamisligil Inflammatory pathways and insulin action Int J Obes Relat Metab Disord 27 suppl 3 2003 S53 S55
145. A.E. Hak, H.A. Pols, and C.D. Stehouwer et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study J Clin Endocrinol Metab 86 2001 4398 4405
146. J.D. Huber Diabetes, cognitive function, and the blood-brain barrier Curr Pharm Des 14 2008 1594 1600
147. H. Wang, E.J. Golob, and M.Y. Su Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls J Magn Reson Imaging 24 2006 695 700
148. G.L. Bowman, J.A. Kaye, M. Moore, D. Waichunas, N.E. Carlson, and J.F. Quinn Blood-brain barrier impairment in Alzheimer disease: stability and functional significance Neurology 68 2007 1809 1814
149. J. Dai, G.F. Vrensen, and R.O. Schlingemann Blood-brain barrier integrity is unaltered in human brain cortex with diabetes mellitus Brain Res 954 2002 311 316
150. M.H. Horani, and A.D. Mooradian Effect of diabetes on the blood brain barrier Curr Pharm Des 9 2003 833 840
151. M. Shibata, S. Yamada, and S.R. Kumar et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J Clin Invest 106 2000 1489 1499
152. N. Iwata, M. Higuchi, and T.C. Saido Metabolism of amyloid-beta peptide and Alzheimer's disease Pharmacol Ther 108 2005 129 148
153. R. Deane, Z. Wu, and A. Sagare et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms Neuron 43 2004 333 344
154. N.C. Alonzo, B.T. Hyman, G.W. Rebeck, and S.M. Greenberg Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels J Neuropathol Exp Neurol 57 1998 353 359
155. B.V. Zlokovic Clearing amyloid through the blood-brain barrier J Neurochem 89 2004 807 811
156. R.D. Bell, and B.V. Zlokovic Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathol 118 2009 103 113
157. G.L. Bowman, and J.F. Quinn Alzheimer's disease and the blood-brain barrier: past, present and future Aging Health 4 2008 47 55
158. H.S. Sharma, R.J. Castellani, M.A. Smith, and A. Sharma The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery Int Rev Neurobiol 102 2012 47 90
159. B.L. Leonard, R.N. Watson, K.M. Loomes, A.R. Phillips, and G.J. Cooper Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes Acta Diabetol 42 2005 162 170
160. J. Capeau Insulin resistance and steatosis in humans Diabetes Metab 34 2008 649 657
161. M. Langeveld, and J.M. Aerts Glycosphingolipids and insulin resistance Prog Lipid Res 48 2009 196 205
162. E.W. Kraegen, and G.J. Cooney Free fatty acids and skeletal muscle insulin resistance Curr Opin Lipidol 19 2008 235 241
163. S.A. Summers Ceramides in insulin resistance and lipotoxicity Prog Lipid Res 45 2006 42 72
164. J.R. Zierath The path to insulin resistance: paved with ceramides? Cell Metab 5 2007 161 163
165. G. Arboleda, T.J. Huang, C. Waters, A. Verkhratsky, P. Fernyhough, and R.M. Gibson Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells Eur J Neurosci 25 2007 3030 3038
166. N.A. Bourbon, L. Sandirasegarane, and M. Kester Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest J Biol Chem 277 2002 3286 3292
167. W.L. Holland, J.T. Brozinick, and L.P. Wang et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance Cell Metab 5 2007 167 179
168. L.A. Consitt, J.A. Bell, and J.A. Houmard Intramuscular lipid metabolism, insulin action, and obesity IUBMB Life 61 2009 47 55
169. S.M. de la Monte, M. Tong, V. Nguyen, M. Setshedi, L. Longato, and J.R. Wands Ceramide-mediated insulin resistance and impairment of cognitive-motor functions J Alzheimers Dis 21 2010 967 984
170. M. Tong, and S.M. de la Monte Mechanisms of ceramide-mediated neurodegeneration J Alzheimers Dis 16 2009 705 714
171. J.E. Boehm, O.V. Chaika, and R.E. Lewis Rac-dependent anti-apoptotic signaling by the insulin receptor cytoplasmic domain J Biol Chem 274 1999 28632 28636
172. F. Bertrand, A. Atfi, and A. Cadoret et al. A role for nuclear factor kappaB in the antiapoptotic function of insulin J Biol Chem 273 1998 2931 2938
173. X. Zhang, N. Tang, T.J. Hadden, and A.K. Rishi Akt, FoxO and regulation of apoptosis Biochim Biophys Acta 1813 2011 1978 1986
174. L. Yan, V.A. Lavin, L.R. Moser, Q. Cui, C. Kanies, and E. Yang PP2A regulates the pro-apoptotic activity of FOXO1 J Biol Chem 283 2008 7411 7420
175. Y.G. Ni, N. Wang, and D.J. Cao et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases Proc Natl Acad Sci USA 104 2007 20517 20522
176. E. Yang, J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death Cell 80 1995 285 291
177. F. Bertrand, C. Philippe, and P.J. Antoine et al. Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway J Biol Chem 270 1995 24435 24441
178. G. Zhou, and M.T. Kuo NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells J Biol Chem 272 1997 15174 15183
179. B. Kaltschmidt, C. Kaltschmidt, T.G. Hofmann, S.P. Hehner, W. Droge, and M.L. Schmitz The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus Eur J Biochem 267 2000 3828 3835
180. S.W. Barger, and M.P. Mattson Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor Brain Res Mol Brain Res 40 1996 116 126
181. S. Camandola, G. Poli, and M.P. Mattson The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons Brain Res Mol Brain Res 85 2000 53 60
182. S.W. Barger, D. Horster, K. Furukawa, Y. Goodman, J. Krieglstein, and M.P. Mattson Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2 + accumulation Proc Natl Acad Sci USA 92 1995 9328 9332
183. R.T. Bartus, R.L. Dean 3rd., B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
184. M.A. Daulatzai Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease J Alzheimers Dis 20 2010 355 367
185. D.M. Araujo, P.A. Lapchak, Y. Robitaille, S. Gauthier, and R. Quirion Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease J Neurochem 50 1988 1914 1923
186. H. Wang, R. Wang, and Z. Zhao et al. Coexistences of insulin signaling-related proteins and choline acetyltransferase in neurons Brain Res 1249 2009 237 243
187. Y.F. Du, P. Yan, S.G. Guo, and C.Q. Qu Effects of fibrillar Abeta(1-40) on the viability of primary cultures of cholinergic neurons and the expression of insulin signaling-related proteins Anat Rec (Hoboken) 294 2011 287 294
188. M.N. Rossor, N.J. Garrett, A.L. Johnson, C.Q. Mountjoy, M. Roth, and L.L. Iversen A post-mortem study of the cholinergic and GABA systems in senile dementia Brain 105 1982 313 330
189. T.D. Bird, S. Stranahan, S.M. Sumi, and M. Raskind Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups Ann Neurol 14 1983 284 293
190. N. Lester-Coll, E.J. Rivera, S.J. Soscia, K. Doiron, J.R. Wands, and S.M. de la Monte Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease J Alzheimers Dis 9 2006 13 33
191. S.V. Ovsepian Differential cholinergic modulation of synaptic encoding and gain control mechanisms in rat hippocampus Neurosci Res 61 2008 92 98
192. T. Shinoe, M. Matsui, M.M. Taketo, and T. Manabe Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus J Neurosci 25 2005 11194 11200
193. T.G. Aigner Pharmacology of memory: cholinergic-glutamatergic interactions Curr Opin Neurobiol 5 1995 155 160
194. N. Matsuoka, and T.G. Aigner Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeys Neuroreport 7 1996 565 568
195. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39
196. L. Jodar, and H. Kaneto Synaptic plasticity: stairway to memory Jpn J Pharmacol 68 1995 359 387
197. A. Kamal, G.J. Biessels, I.J. Urban, and W.H. Gispen Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression Neuroscience 90 1999 737 745
198. F. Gardoni, A. Kamal, and C. Bellone et al. Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats J Neurochem 80 2002 438 447
199. B.C. Shonesy, K. Thiruchelvam, and K. Parameshwaran et al. Central insulin resistance and synaptic dysfunction in intracerebroventricular- streptozotocin injected rodents Neurobiol Aging 33 430 2012 e5 e18
200. H.B. Schioth, S. Craft, S.J. Brooks, W.H. Frey 2nd., and C. Benedict Brain insulin signaling and Alzheimer's disease: current evidence and future directions Mol Neurobiol 46 2012 4 10
201. C.C. Huang, C.C. Lee, and K.S. Hsu The role of insulin receptor signaling in synaptic plasticity and cognitive function Chang Gung Med J 33 2010 115 125
202. J.M. Auerbach, and M. Segal Muscarinic receptors mediating depression and long-term potentiation in rat hippocampus J Physiol 492 Pt 2 1996 479 493
203. J.M. Auerbach, and M. Segal A novel cholinergic induction of long-term potentiation in rat hippocampus J Neurophysiol 72 1994 2034 2040
204. P.M. Kanju, K. Parameshwaran, and C. Sims-Robinson et al. Selective cholinergic depletion in medial septum leads to impaired long term potentiation and glutamatergic synaptic currents in the hippocampus PLoS One 7 2012 e31073
205. K. Parameshwaran, M. Buabeid, and S. Bhattacharya et al. Long term alterations in synaptic physiology, expression of β2 nicotinic receptors and ERK1/2 signaling in the hippocampus of rats with prenatal nicotine exposure Neurobiol Learn Mem 106C 2013 102 111
206. C. Hooper, V. Markevich, and F. Plattner et al. Glycogen synthase kinase-3 inhibition is integral to long-term potentiation Eur J Neurosci 25 2007 81 86
207. S. Peineau, C. Taghibiglou, and C. Bradley et al. LTP inhibits LTD in the hippocampus via regulation of GSK3beta Neuron 53 2007 703 717
208. L. Laviola, A. Natalicchio, and F. Giorgino The IGF-I signaling pathway Curr Pharm Des 13 2007 663 669
209. H. Werner, D. Weinstein, and I. Bentov Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways Arch Physiol Biochem 114 2008 17 22
210. K. Sjogren, K. Wallenius, and J.L. Liu et al. Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism Diabetes 50 2001 1539 1545
211. S. Yakar, J.L. Liu, and A.M. Fernandez et al. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity Diabetes 50 2001 1110 1118
212. L.I. Arwert, J.B. Deijen, and M.L. Drent The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis Growth Horm IGF Res 15 2005 416 422
213. A. Aleman, H.J. Verhaar, and E.H. De Haan et al. Insulin-like growth factor-I and cognitive function in healthy older men J Clin Endocrinol Metab 84 1999 471 475
214. D. Bellar, E.L. Glickman, J. Juvancic-Heltzel, and J. Gunstad Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of healthy, fit older adults Neuroscience 178 2011 133 137
215. E.R. Vardy, P.J. Rice, P.C. Bowie, J.D. Holmes, P.J. Grant, and N.M. Hooper Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease J Alzheimers Dis 12 2007 285 290
216. T. Watanabe, A. Miyazaki, T. Katagiri, H. Yamamoto, T. Idei, and T. Iguchi Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia J Am Geriatr Soc 53 2005 1748 1753
217. A.M. Moloney, R.J. Griffin, S. Timmons, R. O'Connor, R. Ravid, and C. O'Neill Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling Neurobiol Aging 31 2010 224 243
218. K. Sjogren, J.L. Liu, and K. Blad et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice Proc Natl Acad Sci USA 96 1999 7088 7092
219. P. Rotwein, S.K. Burgess, J.D. Milbrandt, and J.E. Krause Differential expression of insulin-like growth factor genes in rat central nervous system Proc Natl Acad Sci USA 85 1988 265 269
220. C. Ayer-le Lievre, P.A. Stahlbom, and V.R. Sara Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus Development 111 1991 105 115
221. Z. Ungvari, and A. Csiszar The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances J Gerontol A Biol Sci Med Sci 67 2012 599 610
222. W.E. Sonntag, F. Deak, and N. Ashpole et al. Insulin-like growth factor-1 in CNS and cerebrovascular aging Front Aging Neurosci 5 2013 27
223. J.L. Trejo, J. Piriz, and M.V. Llorens-Martin et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects Mol Psychiatry 12 2007 1118 1128
224. F. Deak, and W.E. Sonntag Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1 J Gerontol A Biol Sci Med Sci 67 2012 611 625
225. J.L. Trejo, M.V. Llorens-Martin, and I. Torres-Aleman The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis Mol Cell Neurosci 37 2008 402 411
226. W.Q. Zhao, P.N. Lacor, and H. Chen et al. Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta} J Biol Chem 284 2009 18742 18753
227. W. Araki, H. Kume, A. Oda, A. Tamaoka, and F. Kametani IGF-1 promotes beta-amyloid production by a secretase-independent mechanism Biochem Biophys Res Commun 380 2009 111 114
228. S. Freude, M.M. Hettich, and C. Schumann et al. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease FASEB J 23 2009 3315 3324
229. S. Freude, K. Schilbach, and M. Schubert The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease Curr Alzheimer Res 6 2009 213 223
230. B.B. Barnes, J. Chang-Claude, and D. Flesch-Janys et al. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status Cancer Causes Control 20 2009 1985 1996
231. J.B. Douglas, D.T. Silverman, M.N. Pollak, Y. Tao, A.S. Soliman, and R.Z. Stolzenberg-Solomon Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial Cancer Epidemiol Biomarkers Prev 19 2010 2298 2306
232. S. Rinaldi, R. Cleveland, and T. Norat et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies Int J Cancer 126 2010 1702 1715
233. J.J. Sevigny, J.M. Ryan, and C.H. van Dyck et al. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial Neurology 71 2008 1702 1708
234. J.C. Bruning, D. Gautam, and D.J. Burks et al. Role of brain insulin receptor in control of body weight and reproduction Science 289 2000 2122 2125
235. M. Schubert, D. Gautam, and D. Surjo et al. Role for neuronal insulin resistance in neurodegenerative diseases Proc Natl Acad Sci USA 101 2004 3100 3105
236. H. Dudek, S.R. Datta, and T.F. Franke et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661 665
237. G.H. Lee, R. Proenca, and J.M. Montez et al. Abnormal splicing of the leptin receptor in diabetic mice Nature 379 1996 632 635
238. D. Beccano-Kelly, and J. Harvey Leptin: a novel therapeutic target in Alzheimer's disease? Int J Alzheimers Dis 2012 2012 594137
239. J. Harvey, L.J. Shanley, D. O'Malley, and A.J. Irving Leptin: a potential cognitive enhancer? Biochem Soc Trans 33 2005 1029 1032
240. S.J. Greco, S. Sarkar, and J.M. Johnston et al. Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells Biochem Biophys Res Commun 376 2008 536 541
241. D.C. Fewlass, K. Noboa, F.X. Pi-Sunyer, J.M. Johnston, S.D. Yan, and N. Tezapsidis Obesity-related leptin regulates Alzheimer's Abeta FASEB J 18 2004 1870 1878
242. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol Res 50 2001 537 546
243. G.J. Biessels, A. Kamal, and G.M. Ramakers et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats Diabetes 45 1996 1259 1266
244. M. Popovic, G.J. Biessels, R.L. Isaacson, and W.H. Gispen Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task Behav Brain Res 122 2001 201 207
245. G.J. Biessels, A. Kamal, I.J. Urban, B.M. Spruijt, D.W. Erkelens, and W.H. Gispen Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment Brain Res 800 1998 125 135
246. H. Lannert, and S. Hoyer Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats Behav Neurosci 112 1998 1199 1208
247. S. Hoyer, D. Muller, and K. Plaschke Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism J Neural Transm Suppl 44 1994 259 268
248. K. Plaschke, and S. Hoyer Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus Int J Dev Neurosci 11 1993 477 483
249. G. Mayer, R. Nitsch, and S. Hoyer Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats Brain Res 532 1990 95 100
250. E. Grunblatt, M. Salkovic-Petrisic, J. Osmanovic, P. Riederer, and S. Hoyer Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein J Neurochem 101 2007 757 770
251. S.M. de la Monte, M. Tong, N. Lester-Coll, M. Plater Jr., and J.R. Wands Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease J Alzheimers Dis 10 2006 89 109
252. A. Kraska, M.D. Santin, and O. Dorieux et al. In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin PLoS One 7 2012 e46196
253. K.S. Frederiksen, E. Garde, and A. Skimminge et al. Corpus callosum atrophy in patients with mild Alzheimer's disease Neurodegener Dis 8 2011 476 482
254. J.S. Janowsky, J.A. Kaye, and R.A. Carper Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging J Am Geriatr Soc 44 1996 798 803
255. Y. Chen, K. Zhou, and R. Wang et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription Proc Natl Acad Sci USA 106 2009 3907 3912
256. A. Rashidy-Pour ATP-sensitive potassium channels mediate the effects of a peripheral injection of glucose on memory storage in an inhibitory avoidance task Behav Brain Res 126 2001 43 48
257. M.E. Risner, A.M. Saunders, and J.F. Altman et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Pharmacogenomics J 6 2006 246 254
258. L.R. Hanson, and W.H. Frey 2nd. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease BMC Neurosci 9 suppl 3 2008 S5
259. S. Craft, L.D. Baker, and T.J. Montine et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial Arch Neurol 69 2012 29 38
260. M.A. Reger, G.S. Watson, and P.S. Green et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 70 2008 440 448
261. J. Born, T. Lange, W. Kern, G.P. McGregor, U. Bickel, and H.L. Fehm Sniffing neuropeptides: a transnasal approach to the human brain Nat Neurosci 5 2002 514 516
262. M.A. Reger, G.S. Watson, and W.H. Frey 2nd. et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiol Aging 27 2006 451 458
263. M. Donix, G.W. Small, and S.Y. Bookheimer Family history and APOE-4 genetic risk in Alzheimer's disease Neuropsychol Rev 22 2012 298 309
264. C.I. Schnegg, D. Greene-Schloesser, M. Kooshki, V.S. Payne, F.C. Hsu, and M.E. Robbins The PPARdelta agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation Free Radic Biol Med 61C 2013 1 9
265. H.L. Martin, R.B. Mounsey, and K. Sathe et al. A peroxisome proliferator-activated receptor-delta agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease Neuroscience 240 2013 191 203
266. S. Kalinin, J.C. Richardson, and D.L. Feinstein A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease Curr Alzheimer Res 6 2009 431 437
267. U. Smith Pioglitazone: mechanism of action Int J Clin Pract Suppl 2001 13 18
268. I. Bogacka, H. Xie, G.A. Bray, and S.R. Smith The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo Diabetes Care 27 2004 1660 1667
269. L.A. Denner, J. Rodriguez-Rivera, and S.J. Haidacher et al. Cognitive enhancement with rosiglitazone links the hippocampal PPARgamma and ERK MAPK signaling pathways J Neurosci 32 2012 16725 16735a
270. F. Masciopinto, N. Di Pietro, and C. Corona et al. Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice Cell Death Dis 3 2012 e448
271. J.L. Searcy, J.T. Phelps, and T. Pancani et al. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease J Alzheimers Dis 30 2012 943 961
272. J.A. O'Reilly, and M. Lynch Rosiglitazone improves spatial memory and decreases insoluble Abeta(1-42) in APP/PS1 mice J Neuroimmune Pharmacol 7 2012 140 144
273. N. Nicolakakis, and E. Hamel The nuclear receptor PPARgamma as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer's disease Front Aging Neurosci 2 2010 21
274. L. Escribano, A.M. Simon, A. Perez-Mediavilla, P. Salazar-Colocho, J. Del Rio, and D. Frechilla Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model Biochem Biophys Res Commun 379 2009 406 410
275. T. Sato, H. Hanyu, K. Hirao, H. Kanetaka, H. Sakurai, and T. Iwamoto Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease Neurobiol Aging 32 2011 1626 1633
276. M. Gold, C. Alderton, and M. Zvartau-Hind et al. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study Dement Geriatr Cogn Disord 30 2010 131 146
277. E. Barroso, J. Del Valle, and D. Porquet et al. Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARbeta/delta-null mice Biochim Biophys Acta 1832 2013 1241 1248
278. V.A. Gault, P.R. Flatt, and F.P. O'Harte Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes Biochem Biophys Res Commun 308 2003 207 213
279. A. Vella, P. Shah, A.S. Reed, A.S. Adkins, R. Basu, and R.A. Rizza Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans Diabetologia 45 2002 1410 1415
280. V. Parthsarathy, and C. Holscher Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model PLoS One 8 2013 e58784
281. P.L. McClean, V. Parthsarathy, E. Faivre, and C. Holscher The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease J Neurosci 31 2011 6587 6594
282. S.F. McGovern, K. Hunter, and C. Holscher Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain Brain Res 1473 2012 204 213
283. P.L. McClean, V.A. Gault, P. Harriott, and C. Holscher Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease Eur J Pharmacol 630 2010 158 162
284. X.H. Wang, W. Yang, and C. Holscher et al. Val(8)-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid beta peptide in rats J Neurosci Res 91 2013 568 577